1. Home
  2. OFIX vs ASMB Comparison

OFIX vs ASMB Comparison

Compare OFIX & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orthofix Medical Inc. (DE)

OFIX

Orthofix Medical Inc. (DE)

HOLD

Current Price

$9.86

Market Cap

473.3M

Sector

Health Care

ML Signal

HOLD

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$27.34

Market Cap

442.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OFIX
ASMB
Founded
1987
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
473.3M
442.9M
IPO Year
1998
2010

Fundamental Metrics

Financial Performance
Metric
OFIX
ASMB
Price
$9.86
$27.34
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
$17.25
$44.20
AVG Volume (30 Days)
402.5K
258.0K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
29.39
91.78
EPS
N/A
N/A
Revenue
$822,312,000.00
N/A
Revenue This Year
$6.13
N/A
Revenue Next Year
$6.22
$638.39
P/E Ratio
N/A
N/A
Revenue Growth
2.85
N/A
52 Week Low
$8.85
$16.90
52 Week High
$16.99
$39.71

Technical Indicators

Market Signals
Indicator
OFIX
ASMB
Relative Strength Index (RSI) 50.49 57.15
Support Level $8.99 $26.18
Resistance Level $9.90 $31.21
Average True Range (ATR) 0.45 1.64
MACD 0.12 0.52
Stochastic Oscillator 88.39 81.06

Price Performance

Historical Comparison
OFIX
ASMB

About OFIX Orthofix Medical Inc. (DE)

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

Share on Social Networks: